CD5 and lymphoma: In contrast, in T-lymphoblastic leukemia/lymphoma, the neoplastic cells may be negative for surface CD3 staining or positive, but variable CD3 is usually not observed, and the expression of pan T cell antigens, including CD2, CD5, and CD7, may be absent, but not variable.